Cellectar Biosciences Losses Up $CLRB $XHS

Cellectar Biosciences Inc, has announced its first quarter results for the FY-2015. The results shows Net loss per shares of -$0.30 widens by 70% Y/Y, and Operating Cash flow went up to $2.4 million rise by 7.7%. View the full earnings release here.